Showing results (111-120 of 197) with videos related to
Sort By:
Pageof 20
Nature Communications|February 27, 2021
The HIF-1α antisense long non-coding RNA drives a positive feedback loop of HIF-1α mediated transactivation and glycolysisFang Zheng, Jianing Chen, Xiaoqian Zhang, et al.Nature Biotechnology|May 24, 2005
Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptorsErwei Song, Pengcheng Zhu, Sang-Kyung Lee, et al.Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|October 26, 2022
Small Molecular Inhibitors Reverse Cancer Metastasis by Blockading Oncogenic PITPNM3Zihao Liu, Yu Shi, Li Lv, et al.Cancer Communications (London, England)|October 19, 2023
CD146 promotes malignant progression of breast phyllodes tumor through suppressing DCBLD2 degradation and activating the AKT pathwayJiewen Chen, Qingji Xu, Dan Liu, et al.The Journal of Biological Chemistry|December 2, 2016
Distinct Receptor Tyrosine Kinase Subsets Mediate Anti-HER2 Drug Resistance in Breast CancerPeter B Alexander, Rui Chen, Chang Gong, et al.Cell|March 7, 2020
Complement Signals Determine Opposite Effects of B Cells in Chemotherapy-Induced ImmunityYiwen Lu, Qiyi Zhao, Jian-You Liao, et al.Scientific Reports|June 6, 2012
Explicit hypoxia targeting with tumor suppression by creating an "obligate" anaerobic Salmonella Typhimurium strainBin Yu, Mei Yang, Lei Shi, et al.Medicine|December 16, 2014
Nerve fibers in breast cancer tissues indicate aggressive tumor progressionDi Huang, Shicheng Su, Xiuying Cui, et al.Nature Communications|May 31, 2022
Multicenter phase II trial of Camrelizumab combined with Apatinib and Eribulin in heavily pretreated patients with advanced triple-negative breast cancerJieqiong Liu, Ying Wang, Zhenluan Tian, et al.Nature Communications|November 3, 2020
LncRNA DILA1 inhibits Cyclin D1 degradation and contributes to tamoxifen resistance in breast cancerQianfeng Shi, Yudong Li, Shunying Li, et al.Pageof 20